AUAUniversity
357 episodes - English - Latest episode: 2 days ago - ★★★★★ - 32 ratingsThe AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Update Series (2024) Lesson 1: A Case-Based Discussion of Priapism Guidelines
March 27, 2024 05:30 - 28 minutes - 26.4 MBUpdate Series (2024) Lesson 1: A Case-Based Discussion of Priapism Guidelines Now in its 43rd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical t...
AUA2023 Take Home Messages Part 5
March 20, 2024 05:30 - 38 minutes - 35.6 MBAUA2023 Take Home Messages Part 5 Take Home Messages: Take Home Messages: BPH/LUTS Speaker: Dr. Dean Elterman Take Home Messages: Imaging Speaker: Dr. Richard Matulewicz Take Home Messages: Robotic Surgery Speaker: Dr. Andrew Hung Take Home Messages: Surgical Education Speaker: Dr. Simone Thavaseelan
AUA2023 Take Home Messages Part 4
March 06, 2024 06:30 - 35 minutes - 32.6 MBAUA2023 Take Home Messages Part 4 Take Home Messages: Increasing Representation in Urology Speaker: Dr Larissa Bresler Take Home Messages: Healthcare Disparities Speaker: Dr. Adam Murphy Take Home Messages: Transplantation Speaker: Dr. Jason Lee Take Home Messages: Female Urology/Incontinence Speaker: Dr. Yahir Santiago-Lastra
AUA2023 Take Home Messages Part 3
March 06, 2024 06:30 - 43 minutes - 39.8 MBAUA2023 Take Home Messages Part 3 Take Home Messages: Infertility/Andrology Speaker: Dr. Joshua Halpern Take Home Messages: Sexual Dysfunction Speaker: Dr. Peter Tsambarlis Take Home Messages: Pediatrics Speaker: Dr. Kate Kraft Take Home Messages: Global Health/Humanitarian Speaker: Dr. Rajiv Singal
AUA2023 Take Home Messages Part 2
February 28, 2024 06:30 - 38 minutes - 35.2 MBAUA2023 Take Home Messages Part 2 Take Home Messages: Basic Science (Benign) Speaker: Dr. Douglas Strand Take Home Messages: Reconstruction Speaker: Dr. Jessica DeLong Take Home Messages: Endourology/Stones Speaker: Dr. Noah Canvasser Take Home Messages: Infection/Inflammation Speaker: Dr. Chris Doiron
AUA2023 Take Home Messages Part 1
February 22, 2024 17:03 - 39 minutes - 36.1 MBAUA2023 Take Home Messages Part 1 Take Home Messages: Basic Science (Malignant) Speaker: Dr. Douglas Scherr Take Home Messages: Kidney Cancer Speaker: Dr. Amy Luckenbaugh Take Home Messages: Bladder Cancer Speaker: Dr. Jennifer Taylor Take Home Messages: Prostate Cancer Speaker: Dr. Samuel Washington
PARPi: Management of Adverse Events
January 31, 2024 12:15 - 53 minutes - 49 MBPARPi: Management of Adverse Events (2024) CME Available: https://auau.auanet.org/node/39609 Release Date: January, 2024 Expiration Date: January, 2025 LEARNING OBJECTIVES: 1. Identify approved PARPi for prostate cancer and patients who may benefit from PARPi based therapy. 2. Evaluate available clinical safety and efficacy data for PARPi. 3. Describe indications and contraindications for PARPi in patients with advanced prostate cancer. 4. Identify how to manage adverse events that patients...
AUA2023 Journal of Urology Lecture
January 24, 2024 06:30 - 16 minutes - 15.5 MBAUA2023 Journal of Urology Lecture: Surgery Harms Surgeons. What can we do? Speaker: Dr. Kevin Turner
AUA2023 Ramon Guiteras Lecture
January 17, 2024 06:30 - 21 minutes - 19.2 MBAUA2023 Ramon Guiteras Lecture: The Complicated Decisions Required to Eliminate Never Events Speaker: Dr Louis Kavoussi, Smith Institute For Urology.
AUA2023 John Duckett Memorial Lecture
January 10, 2024 06:30 - 19 minutes - 17.7 MBAUA2023 John Duckett Memorial Lecture: Innovation by Necessity: Improving Urodynamics for Children with Spina Bifida Speaker: Dr. Johnathan Routh, Chief of Children's Surgery, Duke University School of Medicine.
AUA2023 John K. Lattimer Lecture
January 03, 2024 06:30 - 18 minutes - 17 MBAUA2023 John K. Lattimer Lecture: Innovation in Urology: From a Seminal “Why” to a Functional “How” Speaker: Dr. Ralph Clayman, Distinguished Professor / Endowed Chair in Endourology, University of California, Irvine.
Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer
December 29, 2023 06:30 - 34 minutes - 31.1 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer CME Available: https://auau.auanet.org/node/39542 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Identify the rationale behind using adjuvant therapies in high-risk non-metastatic kidney cancer and the goals of adjuvant treatment. 2. Describe the adjuvant ther...
The Latest Breakthroughs in Immunotherapy for GU Cancers
December 27, 2023 06:30 - 37 minutes - 33.9 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: The Latest Breakthroughs in Immunotherapy for GU Cancers CME Available: https://auau.auanet.org/node/39543 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Identify the newest immunotherapy drugs approved for prostate, bladder, and kidney cancer, including immune checkpoint inhibitors and other novel immunotherapies. 2. Dis...
Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer
December 25, 2023 06:30 - 37 minutes - 34.2 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer CME Available: auau.auanet.org/node/39487 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify the indications for germline testing in prostate cancer patients. 2. Explain how germline testing is used to identify genetic mutations ...
Novel Imaging for Genitourinary Cancers - Diagnostics and Theranostics
December 22, 2023 06:30 - 32 minutes - 29.5 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Novel Imaging for Genitourinary Cancers - Diagnostics and Theranostics CME Available: https://auau.auanet.org/node/39411 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Review the latest clinical trials investigating the use of PET imaging agents in prostate, kidney, and urothelial cancer, including their diagnostic accura...
Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)
December 20, 2023 06:30 - 40 minutes - 37 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Early Detection of Prostate Cancer: AUA/SUO Guideline (2023) CME Available: https://auau.auanet.org/node/39410 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Discuss the potential benefits, limitations, and controversies associated with prostate cancer screening. 2. Summarize the key recommendations provided in the AUA/SUO...
Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer
December 18, 2023 13:42 - 40 minutes - 37.2 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer CME Available: https://auau.auanet.org/node/39374 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Describe the importance of individualized treatment decision-making and shared decision-making in the management of intermediate and high-...
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test
December 15, 2023 06:30 - 52 minutes - 48.3 MBPARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023) CME Available: https://auau.auanet.org/node/39603 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, the learner will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients, currently available gene panels, and options for testing these men. 2. Explain the importance of testing for germline and somatic mutatio...
Infectious Complications Following Prostate Biopsy
December 13, 2023 06:30 - 40 minutes - 37.2 MBInfectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs CME Available: https://auau.auanet.org/node/39485 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Describe health care costs associated with prostate biopsy infections. 2. Identify the steps where modifications in technique can reduce the risk of complications. 3. Apply modi...
Germline Testing in GU Cancers – How I Do It
December 08, 2023 06:30 - 32 minutes - 29.5 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Germline Testing in GU Cancers – How I Do It CME Available: https://auau.auanet.org/node/39544 Release Date: December, 2023 Expiration Date: December, 2024 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. LEARNING OBJECTIVES: At the conclusion of this activity, participa...
Treatment Intensification for Advanced Prostate Cancer
November 22, 2023 06:30 - 44 minutes - 40.3 MBThe AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Treatment Intensification for Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/39486 Release Date: November, 2023 Expiration Date: November, 2024 LEARNING OBJECTIVES: At the conclusion of these activities, participants will be able to: 1. Identify the latest developments in hormone therapy for advanced prostate cancer, including the use of novel treatments and combinations. 2. Discuss the concept of do...
PARPi: Precision Medicine in Advanced Prostate Cancer
November 17, 2023 13:18 - 51 minutes - 47.3 MBPARPi: Precision Medicine in Advanced Prostate Cancer (2023) CME Available: https://auau.auanet.org/node/39597 Release Date: November, 2023 Expiration Date: November, 2024 At the conclusion of this activity, the learner will be able to: 1. Describe the mechanism of action of PARP inhibitors and the differences among drugs in this class. 2. Describe the role of PARPi treatment alone and in combination with other cancer based therapies. 3. Discuss existing clinical trial data assessing the e...
Prostate Cancer Treatment Intensification
November 08, 2023 06:30 - 27 minutes - 24.8 MBProstate Cancer Treatment Intensification Moderator: Dr. Jay D. Raman Guest: Dr. Michael S. Cookson Acknowledgement: This podcast was funded by and in collaboration with AZ. All opinions are that of the faculty and do not necessarily reflect those of AstraZeneca. Release Date: 11/8/2023 Expiration Date: 11/8/2024
Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline
November 01, 2023 05:30 - 32 minutes - 29.4 MBUpdate Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction Now in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care ...
Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer
October 27, 2023 12:44 - 30 minutes - 28.3 MBDisparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/39088 Release Date: October, 2023 Expiration Date: October, 2024 At the conclusion of these activities, participants will be able to: 1. Recognize current patterns of use for systemic therapies in patients with advanced prostate cancer. 2. Identify disparities in access to care with respect to advanced prostate cancer treatment (ie. race, geography, socioeconomic...
Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects
October 18, 2023 05:30 - 36 minutes - 33.6 MBSystemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side Effects CME Available: https://auau.auanet.org/node/39087 Release Date: October, 2023 Expiration Date: October, 2024 At the conclusion of these activities, participants will be able to: 1. Characterize current treatment paradigm for systemic therapies in managing advanced prostate cancer including doublet and triple therapy. 2. Identify short and long-term side effects of ADT and novel hormonal treatments for advance...
Genetic Testing and Stone Disease
October 11, 2023 05:30 - 32 minutes - 29.3 MBGenetic Testing and Stone Disease Co-host: Kyle Wood, MD Population analysis demonstrated that genetic conditions resulting in stone disease are magnitudes higher than those seen in clinical cohorts, suggesting underdiagnosis. Urologist play a unique role as we often times have many touch points with these patient given their presentation for stone disease. With the advancement of treatments, specifically in primary hyperoxaluria, it is essential that urologist play a more active role in th...
Advances in ADT Part II: A Guide for Urologists
October 04, 2023 05:30 - 44 minutes - 40.4 MBAdvances in ADT Part II: A Guide for Urologists CME Available: https://auau.auanet.org/node/39385 Release Date: October, 2023 Expiration Date: October, 2024 LEARNING OBJECTIVES After participating in this educational activity, participants will be able to: 1. Recognize and characterize different disease states for advance prostate cancer including M0 HSPC, M1 HSPC, M0 CRPC, and M1 CRPC. 2. Discuss the role of a multidisciplinary shared team approach for the diagnosis and management of advan...
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice
September 27, 2023 05:30 - 1 hour - 68.8 MBIncorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice CME Available: https://auau.auanet.org/node/39292 Release Date: September, 2023 Expiration Date: September, 2024 After participating in this educational activity, participants will be able to: 1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Guideline. 2. Assess the impact of newly approved agents on the management of men with Advanced Prostate Cancer. 3. Define M0 CRPC and the tre...
AUA2023 Medical Student Forum
September 13, 2023 12:16 - 58 minutes - 53.7 MBAUA2023 Medical Student Forum
AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide
August 23, 2023 05:29 - 1 hour - 94.1 MBAUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s Guide CME Available: https://auau.auanet.org/node/38322 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients
August 16, 2023 05:29 - 1 hour - 109 MBAUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/38312 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
Treatment for Hormone Sensitive Prostate Cancer
August 09, 2023 05:30 - 49 minutes - 44.9 MBTreatment for Hormone Sensitive Prostate Cancer CME Available: https://auau.auanet.org/node/38703 Treatment for Hormone Sensitive Prostate Cancer (2023), is an exciting new educational offering to update urologists on the latest advancements in the management of hormone sensitive prostate cancer (HSPC), including treatment intensification. This educational initiative is comprised of multiple formats, including a live virtual course, on-demand webcast, and a podcast. This live virtual course...
Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men
August 02, 2023 15:31 - 25 minutes - 23 MBUpdate Series (2023) Lesson 21: Management of Chronic Pelvic Pain in Men Now in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techni...
AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider
July 26, 2023 05:30 - 1 hour - 108 MBAUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider CME Available: https://auau.auanet.org/node/38307 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
AUA2023: Upper-Tract Urothelial Cancer Guidelines
July 19, 2023 05:30 - 2 hours - 112 MBAUA2023: Upper-Tract Urothelial Cancer Guidelines: An Interactive and Evidence-based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video Presentation CME Available: https://auau.auanet.org/node/38327 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: AstraZeneca Merck & Co., Inc. Pfizer, Inc.
AUA2023: What the General Urologist Should Know about Care of Transgender Patients
July 12, 2023 05:30 - 1 hour - 103 MBAUA2023: What the General Urologist Should Know about Care of Transgender Patients CME Available: https://auau.auanet.org/node/38342 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck & Co., Inc.
AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes
July 05, 2023 05:30 - 1 hour - 105 MBAUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas Urovant Sciences, Inc.
AUA2023: Prostate Cancer Diagnosis
June 28, 2023 05:30 - 1 hour - 100 MBAUA2023: Prostate Cancer Diagnosis CME Available: https://auau.auanet.org/node/38302 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
Global Advancements in Bladder Cancer
June 21, 2023 05:00 - 1 hour - 71 MBBased on the findings from the 2022 AUA global survey and needs assessment in bladder cancer, the AUA has developed this new series of virtual courses to update urologists on the latest advancements in bladder cancer care. This course will address new and emerging treatment options for non‐muscle invasive (NMIBC) and muscle‐invasive bladder cancer (MIBC) with a focus on identifying side effects and interventions, review of guidelines specific to first and second line therapies, timing and usa...
AUA2023: Advancing Gender Equity in Urology: Allyship for Men and Advocacy for Women
June 14, 2023 05:29 - 1 hour - 95.8 MBAUA2023: Advancing Gender Equity in Urology: Allyship for Men and Advocacy for Women CME Available: https://auau.auanet.org/node/38337/ CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck & Co., Inc.
AUA2023: Genetics and Genomics of GU Malignancies: Applications into Your Clinical Practice
June 07, 2023 05:30 - 1 hour - 106 MBAUA2023: Genetics and Genomics of GU Malignancies: Applications into Your Clinical Practice CME Available: https://auau.auanet.org/node/38317 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
AUA2023: AUA Guidelines on Advanced Prostate Cancer
May 31, 2023 05:30 - 1 hour - 104 MBAUA2023: AUA Guidelines on Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/38297 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
AUA2023: Diversity, Equity and Inclusion in Urology: What Do We Need to Know
May 24, 2023 05:30 - 1 hour - 76.9 MBAUA2023: Diversity, Equity and Inclusion in Urology: What Do We Need to Know CME Available: https://auau.auanet.org/node/38332/ CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck & Co., Inc.
AUA2023: The Changing Face of Advanced Prostate Cancer
May 17, 2023 05:30 - 1 hour - 98.8 MBAUA2023: The Changing Face of Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/38292 Release Date: May, 2023 Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc.
AUA2023: Contemporary Pharmacotherapy for OAB 2023
May 10, 2023 05:30 - 2 hours - 116 MBAUA2023: Contemporary Pharmacotherapy for OAB 2023 CME Available: https://auau.auanet.org/node/38282 Release Date: May, 2023 Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas Urovant Sciences, Inc. LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Define the similarities and differences between the various oral pharmacotherapies for OAB. 2. Review the principles of physiology and pharmacotherapy ...
Live from AUA2023: Highlights in BPH
May 01, 2023 19:48 - 58 minutes - 80.6 MBLive from AUA2023: Highlights in BPH is a panel discussion filmed during the 2023 AUA Annual Meeting! CME Available: https://auau.auanet.org/node/38008 Release Date: May, 2023 Expiration Date: May, 2024 ACKNOWLEDGEMENTS This educational activity is supported by independent educational grants from: Cook Medical, LLC. Olympus Corporation of the Americas
Live from AUA2023: Highlights in Advanced Prostate Cancer
April 29, 2023 23:08 - 1 hour - 83.3 MBLive from AUA2023: Highlights in Advanced Prostate Cancer is a panel discussion filmed during the 2023 AUA Annual Meeting! CME Available: https://auau.auanet.org/node/38002 Expiration Date: April, 2024 This activity is designed to increase the urologist’s understanding of how to translate the latest scientific advances into their routine clinical practice, improving the care of patients with advanced prostate cancer. Faculty will review the latest advances in prostate cancer including the ...
The Role of PARP Inhibitors in Advanced Prostate Cancer
April 29, 2023 23:08 - 1 hour - 97.7 MBThe Role of PARP Inhibitors in Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/38241 Release Date: May, 2023 Expiration Date: May, 2024 Based on the documented need from the most recent AUA needs assessment in advanced prostate cancer, this symposium will address the role of PARP Inhibitor treatment, as well as evidence and outcomes of PARP Inhibitors as outlined in the newly amended Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline. At the conclusion of this activi...
AUA2022: Complications of Vaginal Mesh
April 19, 2023 13:09 - 2 hours - 113 MBComplications of Vaginal Mesh Course Director: Kamran Sajadi, MD Course Faculty: Farzeen Firoozi, MD Christopher F. Tenggardjaja, MD